Julia Eastland
Chief Executive Officer bei HARPOON THERAPEUTICS, INC.
Vermögen: 5 907 $ am 31.03.2024
Profil
Julia Marie Eastland is currently the President, Chief Executive Officer & Secretary at Harpoon Therapeutics, Inc. and an Independent Director at Dynavax Technologies Corp.
Previously, she held positions such as Finance Director at Biovail Corp., Independent Director at Graybug Vision, Inc., Director-Finance & Planning at Encore Media Group, Director at Nevis Brands, Inc., Finance Manager at Amgen, Inc., Vice President-Strategic Planning at Dendreon Corp., CFO, Secretary & VP-Corporate Development at Cascadian Therapeutics LLC, Chief Financial Officer & VP-Operations at Viral Logic Systems Technology Corp., Manager-Business & International Finance at Science Magazine, and Financial Manager at Discovery Channel.
She also served as the Chief Financial & Business Officer at Rainier Therapeutics, Inc. from 2018 to 2020, and as the Chief Operating & Financial Officer at ReCode Therapeutics, Inc. from 2020 to 2021.
Ms. Eastland completed her undergraduate degree at Colorado State University and holds an MBA from the University of Edinburgh Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CALCIMEDICA, INC.
0,01% | 23.03.2023 | 1 420 ( 0,01% ) | 5 907 $ | 31.03.2024 |
| 26.05.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Julia Eastland
| Unternehmen | Position | Beginn |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Director/Board Member | 17.07.2020 |
| HARPOON THERAPEUTICS, INC. | Chief Executive Officer | 08.11.2021 |
Ehemalige bekannte Positionen von Julia Eastland
| Unternehmen | Position | Ende |
|---|---|---|
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Director of Finance/CFO | 01.11.2021 |
| NEVIS BRANDS INC. | Director/Board Member | 01.12.2020 |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Director of Finance/CFO | 01.01.2020 |
| CASCADIAN THERAPEUTICS INC (USA) | Director of Finance/CFO | 09.03.2018 |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Director of Finance/CFO | 01.01.2010 |
Ausbildung von Julia Eastland
| Colorado State University | Undergraduate Degree |
| University of Edinburgh Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| NEVIS BRANDS INC. | Health Technology |
| HARPOON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Viral Logic Systems Technology Corp.
Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Health Technology |
| Encore Media Group | |
Science Magazine
 Science Magazine Internet Software/ServicesTechnology Services Science Magazine is a peer-reviewed academic journal published by the American Association for the Advancement of Science. It is one of the top academic journals in the world and has been in circulation since 1880. The magazine delivers impactful research, daily news, expert commentary, and career resources to its subscriber base of around 130,000. Science is a leading multidisciplinary, international journal that covers breakthroughs and policy analysis and news. | Technology Services |
Discovery Channel
 Discovery Channel BroadcastingConsumer Services Part of Warner Bros. The private company is based in Bethesda, MD. Discovery, Inc., Discovery Channel is a provider of television broadcasting services. | Consumer Services |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Health Technology |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
